An increasing number of metabolic syndrome components was significantly associated with progressively compromised cardiac structure and function, including increased left ventricular mass (p<0.001).
Cross-Sectional (n=684)
Is an increasing number of components of the metabolic syndrome associated with cardiac structural and functional abnormalities in adults aged 45 years or over?
Increasing severity of metabolic syndrome is associated with progressively worse cardiac structure and diastolic function, independent of traditional coronary heart disease risk scores.
Tasa de eventos absoluta: 129.9% vs 100.1%
valor p: p=<0.001
BACKGROUND: We aimed to assess whether we could identify a graded association between increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities independently of predicted risk of coronary heart disease by the Framingham risk score. METHODS: We conducted a cross-sectional study on a random sample of the urban population of Porto aged 45 years or over. Six hundred and eighty-four participants were included. Data were collected by a structured clinical interview with a physician, ECG and a transthoracic M-mode and 2D echocardiogram. The metabolic syndrome was defined according to ATPIII-NCEP. The association between the number of features of the metabolic syndrome and the cardiac structural and functional abnormalities was assessed by 3 multivariate regression models: adjusting for age and gender, adjusting for the 10-year predicted risk of coronary heart disease by Framingham risk score and adjusting for age, gender and systolic blood pressure. RESULTS: There was a positive association between the number of features of metabolic syndrome and parameters of cardiac structure and function, with a consistent and statistically significant trend for all cardiac variables considered when adjusting for age and gender. Parameters of left ventricular geometry patterns, left atrial diameter and diastolic dysfunction maintained this trend when taking into account the 10-year predicted risk of coronary heart disease by the Framingham score as an independent variable, while left ventricular systolic dysfunction did not. The prevalence of left ventricular diastolic dysfunction, and the mean left ventricular mass, left ventricular diameter and left atrial diameter increased significantly with the number of features of the metabolic syndrome when additionally adjusting for systolic blood pressure as a continuous variable. CONCLUSION: Increasing severity of metabolic syndrome was associated with increasingly compromised structure and function of the heart. This association was independent of Framingham risk score for indirect indices of diastolic dysfunction but not systolic dysfunction, and was not explained by blood pressure level.
Azevedo et al. (Thu,) conducted a cross-sectional in Metabolic syndrome and cardiac structural and functional abnormalities (n=684). Increasing number of metabolic syndrome components vs. Zero components of the metabolic syndrome was evaluated on Left ventricular mass/height (g/m) adjusted for age and gender (trend across 0 to 4-5 components) (p=<0.001). An increasing number of metabolic syndrome components was significantly associated with progressively compromised cardiac structure and function, including increased left ventricular mass (p<0.001).